• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Kavalactones Mixture

Kavalactones Mixture

Product ID K0282
Cas No.
Purity ≥98%
Product Unit SizeCostQuantityStock
1 ml $933.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

100 µg each of 13 kava compounds/ mL acetonitrile.

Kavalactones are found in Piper methysticum and exert a wide variety of activities in vitro and in vivo, including antinociceptive, anxiolytic, hypnotic, anticonvulsant, and anti-inflammatory effects. Kavalactones shorten sleep latency and decrease awake time in sleep-disturbed rats and effectively treat short-term anxiety in humans. In animals, these compounds also activate Nrf2, a transcription factor protective against aβ-induced neurotoxicity in Alzheimer’s disease and inhibit MPTP-induced loss of DA, tyrosine hydroxylase, and nigral neurons in models of Parkinson’s disease. Additionally, kavalactones modulate Na+, K+, and Ca2+ ion channel signaling as well as chemical and thermal pain nociception.

Product Info

Purity

≥98%

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

Info Sheet

K0282 Info Sheet PDF

References

Kormann EC, Amaral Pde A, David M, et al. Kavain analogues as potential analgesic agents. Pharmacol Rep. 2012;64(6):1419-26. PMID: 23406752.

Tsutsui R, Shinomiya K, Takeda Y, et al. Hypnotic and sleep quality-enhancing properties of kavain in sleep-disturbed rats. J Pharmacol Sci. 2009 Nov;111(3):293-8. PMID: 19881224.

Wruck CJ, Götz ME, Herdegen T, et al. Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol. 2008 Jun;73(6):1785-95. PMID: 18334601.

Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2003;(1):CD003383. PMID: 12535473.

Grunze H, Langosch J, Schirrmacher K, et al. Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Nov;25(8):1555-70. PMID: 11642654.

Schmidt N, Ferger B. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease. Synapse. 2001 Apr;40(1):47-54. PMID: 11170221.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • R3477

    Ritodrine Hydrochloride

    Phenylethylamine; β2-adrenergic agonist, SK/BK...

    ≥98%
  • T7135

    Triticonazole

    Triazole; 14-α demethylase inhibitor, potentia...

    ≥95%
  • A2046

    Aflatoxin B2

    Mycotoxin produced by species of Aspergillus; D...

    ≥98%
  • W7201

    WS6

    Islet α/β cell proliferation stimulator.

    ≥98%
  • K1677

    Ketoprofen

    NSAID; COX-1/2 and lactate dehydrogenase inhibi...

    ≥98%
  • U6854

    Urocortin, human

    Endogenous peptide hormone, involved in feeding...

    ≥98%
  • C0824

    CCG1423

    Serum response factor inhibitor and MRTF-A bind...

    ≥98%
  • V0145

    Valinomycin

    Peptide, neutral ionophore.

    ≥98%
  • M4100

    MK-0524

    DP1 antagonist.

    ≥99%
  • W2800

    WH-4-023

    Lck, Src, SIK inhibitor.

    ≥99 %
  • E2002

    Efaroxan Hydrochloride

    α2-adrenergic and imidazoline-1 antagonist, AT...

    ≥99%
  • A464766

    Altenuene

    Alternaria mycotoxin which may be found in food...

    ≥98%
  • O9397

    Oxytetracycline Hydrochloride

    Tetracycline; protein translation inhibitor.

    ≥95%
  • A7034

    Aripiprazole

    D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...

    ≥98%
  • V182705

    Verubecestat

    BACE1 inhibitor

    ≥98%
  • A4646

    ALLN

    Calpain I/II inhibitor.

    ≥98%
  • N4972

    NMS-873

    Valosin-containing protein inhibitor.

    ≥98%
  • A4854

    β-Amyloid Peptide (1-42), rat

    Endogenous APP peptide cleavage product, primar...

    ≥95%
  • A480000

    AM251

    CB1 receptor antagonist/ inverse agonist.

    ≥97%
  • D5868

    Doramapimod

    JNK, ALK, p38 MAPK inhibitor.

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only